- letzte 200 News
- Archiv
| Zeit | Aktuelle Nachrichten | Rating | Leser | ||
|---|---|---|---|---|---|
| Di | Liberty Gold Corp.: Liberty Gold Announces the Appointment of Lauren Roberts to the Board of Directors and Reports Q2 2025 Financial and Operating Results | 38 | VANCOUVER, British Columbia, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX: LGD; OTCQX: LGDTF) ("Liberty Gold" or the "Company"), is pleased to announce the appointment of Lauren Roberts... ► Artikel lesen | ||
| Di | Montage Gold Corp: Montage Gold Reports on Its Q2 and H1-2025 Activities | 41 | Koné project construction on-budget and well on-schedule • Strong continued exploration focus • Robust liquidity sources CONSTRUCTION ACTIVITIES Over 3.0 million hours worked without a Lost... ► Artikel lesen | ||
| Di | Peyto Exploration & Development Corp.: Peyto Reports Second Quarter 2025 Results | 253 | CALGARY, Alberta, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto" or the "Company") is pleased to report operating and financial results for the second... ► Artikel lesen | ||
| Di | Clairvest Group Inc.: Clairvest Reports Fiscal 2026 First Quarter Results | 40 | TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Clairvest Group Inc. (TSX: CVG) today reported results for the fiscal 2026 first quarter ended June 30, 2025. (All figures are in Canadian dollars unless... ► Artikel lesen | ||
| Di | Signing Day Sports, Inc.: Signing Day Sports Announces Selected Financial Results for Quarter Ended June 30, 2025, and Provides Business Update | 27 | SCOTTSDALE, AZ, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Signing Day Sports, Inc. ("Signing Day Sports" or the "Company") (NYSE American: SGN), the developer of the Signing Day Sports app and platform to... ► Artikel lesen | ||
| Di | Martinrea International Inc. Reports Second Quarter Results and Declares Dividend | 45 | TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX: MRE), a diversified and global automotive supplier engaged in the design, development and manufacturing of highly engineered... ► Artikel lesen | ||
| Di | Strong Quarter for Dundee Corporation Includes Inaugural Royalty Revenue | 49 | TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) -- "This quarter, we began recognizing revenue from our royalty interest in the Borborema Gold Project, signaling the start of a new, recurring revenue stream.... ► Artikel lesen | ||
| Di | Mexco Energy Corp.: Mexco Energy Corporation Reports Financial Results for First Quarter | 44 | MIDLAND, TX, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Mexco Energy Corporation (NYSE American: MXC) today reported net income of $241,951, or $0.12 per diluted share, for the quarter ending June 30, 2025... ► Artikel lesen | ||
| Di | Reed's, Inc.: Reed's Reports Second Quarter 2025 Results | 44 | NORWALK, Conn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (OTCQX: REED) ("Reed's" or the "Company"), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, is reporting... ► Artikel lesen | ||
| Di | Satellogic, Inc.: Satellogic Reports Second Quarter Financial Results | 43 | 27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised to Deliver NextGen Satellite and Technology Transfer to Malaysia's Earth Observation... ► Artikel lesen | ||
| Di | Antalpha Platform Holding Company: Antalpha Reports Second Quarter 2025 Financial Results | 118 | SINGAPORE, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Antalpha Platform Holding Company (NASDAQ: ANTA) ("Antalpha" or the "Company"), a leading institutional digital asset financing platform, today announced... ► Artikel lesen | ||
| Di | Stran & Company, Inc.: Stran & Company Achieves 95.2% Increase in Sales to Approximately $32.6 Million for the Second Quarter of 2025 | 34 | Reports Positive Net Income for the Three and Six Months Ended June 30, 2025 Executes Share Repurchase Program and Maintains Strong Balance Sheet with Approximately $18.1 Million in Cash... ► Artikel lesen | ||
| Di | Eupraxia Pharmaceuticals Inc.: Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update | 39 | Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in H2 2026Announced positive data from Phase 1b/2a RESOLVE supporting... ► Artikel lesen | ||
| Di | Navigator Holdings Ltd.: Navigator Gas Announces Preliminary Second Quarter 2025 Results (Unaudited) | 39 | LONDON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Second Quarter Financial Highlights On August 12, 2025, the Board of Navigator Holdings Ltd., (NYSE: NVGS) ("Navigator Holdings", "Navigator Gas", "our"... ► Artikel lesen | ||
| Di | Okeanis Eco Tankers Corp. - Unaudited Condensed Financial Statements for the Second Quarter and Six-Month Period of 2025 | 53 | ATHENS, Greece, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Okeanis Eco Tankers Corp. (together with its subsidiaries, unless context otherwise dictates, "OET" or the "Company") (NYSE: ECO, OSE: OET) today... ► Artikel lesen | ||
| Di | Sienna Senior Living: Sienna Reports Second Quarter 2025 Financial Results and Publishes 2025 Impact Report | 44 | MARKHAM, Ontario, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. ("Sienna" or the "Company") (TSX: SIA) today announced its financial results for the three and six months ended June 30... ► Artikel lesen | ||
| Di | vTv Therapeutics Inc.: vTv Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | 44 | • First study participant randomized in Phase 3 CATT1 trial evaluating cadisegliatin for the treatment of type 1 diabetes with data expected in second half of 2026 • Cadisegliatin intellectual... ► Artikel lesen | ||
| Di | Woodward, Inc.: Shawn McLevige Appointed as President of Woodward's Aerospace Segment | 67 | FORT COLLINS, Colo., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Woodward, Inc. (NASDAQ: WWD), a global leader in energy controls for aerospace and industrial markets, today announced key leadership changes... ► Artikel lesen | ||
| Di | Team, Inc. Reports Second Quarter 2025 Results | 49 | SUGAR LAND, Texas, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Team, Inc. (NYSE: TISI) ("TEAM" or the "Company"), a global, leading provider of specialty industrial services offering customers access to a full... ► Artikel lesen | ||
| Di | DoubleDown Interactive Co., Ltd.: DoubleDown Interactive Reports Second Quarter 2025 Financial Results | 51 | SEOUL, South Korea, Aug. 12, 2025 (GLOBE NEWSWIRE) -- DoubleDown Interactive Co., Ltd. (NASDAQ: DDI) ("DoubleDown" or the "Company"), a leading developer and publisher of digital games on mobile and... ► Artikel lesen | ||
| Di | Oxley Bridge Acquisition Limited Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing August 15, 2025 | 41 | Vancouver, BC, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Oxley Bridge Acquisition Limited (Nasdaq: OBAWU) (the "Company") announced today that, commencing August 15, 2025, holders of the units sold in the... ► Artikel lesen | ||
| Di | Gouverneur Bancorp, Inc. Announces Appointment of New President and Chief Executive Officer | 42 | GOUVERNEUR, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Gouverneur Bancorp, Inc. (OTCQB Marketplace: GOVB) (the "Company"), the holding company for Gouverneur Savings and Loan Association (the "Bank")... ► Artikel lesen | ||
| Di | Archrock Announces Dual Listing on NYSE Texas | 43 | HOUSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Archrock, Inc. (NYSE:AROC) ("Archrock") announced today the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities... ► Artikel lesen | ||
| Di | Lyell Immunopharma, Inc: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2025 | 53 | Presented positive new clinical data demonstrating high rates of durable complete responses from the Phase 1/2 trial of LYL314 for the treatment of aggressive large B-cell lymphomaInitiated the PiNACLE... ► Artikel lesen | ||
| Di | Adagene Inc.: Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates | 58 | Muzastotug (ADG126) Phase 1b/2 in MSS CRC shows 19.4-month median OS (mOS) in 10 mg/kg dose cohorts; mOS for 20 mg/kg cohorts has not yet been reached Alignment with FDA on Phase 2 and Phase 3 trial... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .